UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Early symptoms of systemic lupus erythematosus (SLE) recalled by 339 SLE patients

Lupus, 2018-08, Vol.27 (9), p.1431-1436

2018

Volltextzugriff (PDF)

Cutting Edge: Reversal of Murine Lupus Nephritis with CTLA4Ig and Cyclophosphamide

The Journal of immunology (1950), 2001-03, Vol.166 (5), p.2913-2916

2001

Volltextzugriff (PDF)

THU0349 Early Symptoms of Systemic Lupus Erythematosus (SLE) Recalled by 337 SLE Patients

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.313

2016

Volltextzugriff (PDF)

SAT0415 Performance of Anti-Nuclear Antibodies (ANA) for Classifying Systemic Lupus Erythematosus (SLE): A Systematic Literature Review and Meta-Regression of Diagnostic Data

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.809-810

2015

Volltextzugriff (PDF)

AB0512 Use of Nominal Group Technique To Facilitate Item Reduction for Sle Classification Criteria Development

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1080

2016

Volltextzugriff (PDF)

Block and tackle: CTLA4Ig takes on lupus

Lupus, 2005-01, Vol.14 (3), p.197-203

2005

Volltextzugriff (PDF)

Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways

The Journal of immunology (1950), 1997-10, Vol.159 (7), p.3104

1997

Volltextzugriff (PDF)

An Inactivating Point Mutation in the Inhibitory Wedge of CD45 Causes Lymphoproliferation and Autoimmunity

Cell, 2000-12, Vol.103 (7), p.1059-1070

2000

Volltextzugriff (PDF)

A randomized trial of stress management for the prevention of new brain lesions in MS

Neurology, 2012-07, Vol.79 (5), p.412

2012

Volltextzugriff (PDF)

Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

BMJ (Online), 2002-06, Vol.324 (7352), p.1488

International edition, 2002

Volltextzugriff (PDF)

THU0349 Early Symptoms of Systemic Lupus Erythematosus (SLE) Recalled by 337 SLE Patients: Table 1

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.313-313

2016

Volltextzugriff (PDF)

Treatment of autoimmunity by inhibition of T cell costimulation

Advances in experimental medicine and biology, 2001, Vol.490, p.113

2001

Volltextzugriff (PDF)

Effects of Anti-B7 Monoclonal Antibodies on Humoral Immune Responses

Journal of autoimmunity, 1999-03, Vol.12 (2), p.101-108

1999

Volltextzugriff (PDF)

The CD28-B7 costimulatory pathway and its role in autoimmune disease

Journal of leukocyte biology, 1997-08, Vol.62 (2), p.156-162

1997

Volltextzugriff (PDF)

On the horizon: clinical trials of new immunosuppressive strategies for autoimmune diseases

Transplantation proceedings, 1998-12, Vol.30 (8), p.4027-4028

1998

Volltextzugriff (PDF)

AB0512 Use of Nominal Group Technique To Facilitate Item Reduction for Sle Classification Criteria Development: Table 1

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1080-1081

2016

Volltextzugriff (PDF)

Treatment of autoimmune diseases by inhibition of T-cell costimulation

Modern rheumatology, 2002-03, Vol.12 (1), p.1-4

2002

Volltextzugriff (PDF)

Advances in managing ankylosing spondylitis

F1000 prime reports, 2014, Vol.6, p.78-78

2014

Volltextzugriff (PDF)

In situ hybridization detection of marked differences in pre-proopiomelanocortin messenger ribonucleic acid content of individual corticotropes and melanotropes

Endocrinology (Philadelphia), 1989-03, Vol.124 (3), p.1359-1364

1989

Volltextzugriff (PDF)

Increased Regulatory T Cell Prevalence and Retained Capacity to Suppress Effector T Cells During Disease in NZB/W Lupus Mice

Clinical immunology (Orlando, Fla.), 2007-01, Vol.123, p.S102-S102

2007

Volltextzugriff (PDF)

Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis

Arthritis and rheumatism, 2002-08, Vol.47 (4), p.445-449

2002

Volltextzugriff (PDF)

Treatment of autoimmune diseases by inhibition of T-cell costimulation

Modern rheumatology, 2002-03, Vol.12 (1), p.1

2002

Volltextzugriff (PDF)

Catastrophic antiphospholipid syndrome. Response to repeated plasmapheresis over three years

Arthritis and rheumatism, 1997-08, Vol.40 (8), p.1534-1539

1997

Volltextzugriff (PDF)

NSAIDs and acetaminophen

The journal of pain, 2004-04, Vol.5 (3), p.S65

2004

Volltextzugriff (PDF)

Rheumatic Manifestations of Cancer

Rheumatic diseases clinics of North America, 2011-11, Vol.37 (4), p.489-505

2011

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(53)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(23)
Humans
(19)
Animals
(15)
Biological And Medical Sciences
(13)
Female
(11)
Medical Sciences
(10)
Male
(9)
Rheumatology
(9)
Abatacept
(8)
Mice
(7)
Middle Aged
(6)
Adult
(5)
Aged
(5)
Antigens, Cd
(5)
Ctla-4 Antigen
(5)
Immunology
(5)
T-Lymphocytes - Immunology
(5)
Drug Therapy, Combination
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Early symptoms of systemic lupus erythematosus (SLE) recalled by 339 SLE patients

Cutting Edge: Reversal of Murine Lupus Nephritis with CTLA4Ig and Cyclophosphamide

THU0349 Early Symptoms of Systemic Lupus Erythematosus (SLE) Recalled by 337 SLE Patients

SAT0415 Performance of Anti-Nuclear Antibodies (ANA) for Classifying Systemic Lupus Erythematosus (SLE): A Systematic Literature Review and Meta-Regression of Diagnostic Data

AB0512 Use of Nominal Group Technique To Facilitate Item Reduction for Sle Classification Criteria Development

Block and tackle: CTLA4Ig takes on lupus

Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways

An Inactivating Point Mutation in the Inhibitory Wedge of CD45 Causes Lymphoproliferation and Autoimmunity

A randomized trial of stress management for the prevention of new brain lesions in MS

Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

THU0349 Early Symptoms of Systemic Lupus Erythematosus (SLE) Recalled by 337 SLE Patients: Table 1

Treatment of autoimmunity by inhibition of T cell costimulation

Effects of Anti-B7 Monoclonal Antibodies on Humoral Immune Responses

The CD28-B7 costimulatory pathway and its role in autoimmune disease

On the horizon: clinical trials of new immunosuppressive strategies for autoimmune diseases

AB0512 Use of Nominal Group Technique To Facilitate Item Reduction for Sle Classification Criteria Development: Table 1

Treatment of autoimmune diseases by inhibition of T-cell costimulation

Advances in managing ankylosing spondylitis

In situ hybridization detection of marked differences in pre-proopiomelanocortin messenger ribonucleic acid content of individual corticotropes and melanotropes

Increased Regulatory T Cell Prevalence and Retained Capacity to Suppress Effector T Cells During Disease in NZB/W Lupus Mice

Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis

Treatment of autoimmune diseases by inhibition of T-cell costimulation

Catastrophic antiphospholipid syndrome. Response to repeated plasmapheresis over three years

NSAIDs and acetaminophen

Rheumatic Manifestations of Cancer

Suchergebnisse filtern